AIM ImmunoTech Stock Price - AIM

-0.03 (-2.83%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
AIM ImmunoTech Inc AIM AMEX Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.03 -2.83% 1.03 1.02 1.0499 1.03 1.06 12:06:48
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
1,239 812,396 $ 1.03 $ 835,200 4,667,982 0.381 - 3.88
Last Trade Time Type Quantity Stock Price Currency
12:06:48 1,000 $ 1.03 USD

AIM ImmunoTech Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 8.44M 8.26M $ 2.52M -9.56 - 5.17M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
699.13k $ - 0.00% - -

more financials information »

AIM ImmunoTech News

Loading Messages....

Latest AIM Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AIM Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.,162,162-0.12-10.43%
1 Month1.131.740.781.145,691,130-0.10-8.85%
3 Months0.451.740.38771.042,864,7460.58128.89%
6 Months1.963.880.3811.061,679,193-0.93-47.45%
1 Year1.963.880.3811.061,679,193-0.93-47.45%
3 Years1.963.880.3811.061,679,193-0.93-47.45%
5 Years1.963.880.3811.061,679,193-0.93-47.45%

AIM ImmunoTech Description

AIM ImmunoTech Inc is a US-based specialty pharmaceutical company. It is engaged in the clinical development of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune-based disorders. The products of the firm are Alferon N Injection and the experimental therapeutic Ampligen. Alferon N Injection is approved for a category of STD infection, and Ampligen represents a RNA being developed for viral diseases and disorders of the immune system. The sales revenue of the company is derived from the United States.

Your Recent History
AIM Immuno..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.